JP2004531563A5 - - Google Patents

Download PDF

Info

Publication number
JP2004531563A5
JP2004531563A5 JP2002591507A JP2002591507A JP2004531563A5 JP 2004531563 A5 JP2004531563 A5 JP 2004531563A5 JP 2002591507 A JP2002591507 A JP 2002591507A JP 2002591507 A JP2002591507 A JP 2002591507A JP 2004531563 A5 JP2004531563 A5 JP 2004531563A5
Authority
JP
Japan
Prior art keywords
formula
compound
benzazepine
pyrimido
imidazo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002591507A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004531563A (ja
JP4068466B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/005121 external-priority patent/WO2002094834A1/en
Publication of JP2004531563A publication Critical patent/JP2004531563A/ja
Publication of JP2004531563A5 publication Critical patent/JP2004531563A5/ja
Application granted granted Critical
Publication of JP4068466B2 publication Critical patent/JP4068466B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002591507A 2001-05-18 2002-05-08 GABAA受容体修飾物質としてのイミダゾ〔1,5−a〕ピリミド〔5,4−d〕〔1〕ベンズアゼピン誘導体 Expired - Fee Related JP4068466B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01112222 2001-05-18
PCT/EP2002/005121 WO2002094834A1 (en) 2001-05-18 2002-05-08 Imidazo [1,5-a] pyrimido [5,4-d] benzazepine derivatives as gaba a receptor modulators

Publications (3)

Publication Number Publication Date
JP2004531563A JP2004531563A (ja) 2004-10-14
JP2004531563A5 true JP2004531563A5 (enExample) 2005-08-25
JP4068466B2 JP4068466B2 (ja) 2008-03-26

Family

ID=8177471

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002591507A Expired - Fee Related JP4068466B2 (ja) 2001-05-18 2002-05-08 GABAA受容体修飾物質としてのイミダゾ〔1,5−a〕ピリミド〔5,4−d〕〔1〕ベンズアゼピン誘導体

Country Status (37)

Country Link
US (1) US6686352B2 (enExample)
EP (1) EP1399448B1 (enExample)
JP (1) JP4068466B2 (enExample)
KR (1) KR100533406B1 (enExample)
CN (1) CN1230436C (enExample)
AR (1) AR033753A1 (enExample)
AT (1) ATE283857T1 (enExample)
AU (1) AU2002338898B2 (enExample)
BG (1) BG108369A (enExample)
BR (1) BR0209859A (enExample)
CA (1) CA2446903C (enExample)
CZ (1) CZ20033355A3 (enExample)
DE (1) DE60202147T2 (enExample)
DK (1) DK1399448T3 (enExample)
EC (1) ECSP034851A (enExample)
ES (1) ES2232778T3 (enExample)
GT (1) GT200200087A (enExample)
HR (1) HRP20030890A2 (enExample)
HU (1) HUP0400743A3 (enExample)
IL (2) IL158572A0 (enExample)
JO (1) JO2297B1 (enExample)
MA (1) MA27024A1 (enExample)
MX (1) MXPA03010529A (enExample)
MY (1) MY127570A (enExample)
NO (1) NO20035104D0 (enExample)
NZ (1) NZ529097A (enExample)
PA (1) PA8545201A1 (enExample)
PE (1) PE20030041A1 (enExample)
PL (1) PL366846A1 (enExample)
PT (1) PT1399448E (enExample)
RU (1) RU2287531C2 (enExample)
SI (1) SI1399448T1 (enExample)
SK (1) SK15252003A3 (enExample)
TW (1) TWI251489B (enExample)
WO (1) WO2002094834A1 (enExample)
YU (1) YU90003A (enExample)
ZA (1) ZA200308544B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS50568B8 (sr) 2004-05-14 2019-08-30 Millennium Pharm Inc Jedinjenja i postupci za inhibiciju mitotičke progresije inhibiranjem aurora kinaze
CA2582235A1 (en) * 2004-10-04 2006-04-20 Millennium Pharmaceuticals, Inc. Lactam compounds useful as protein kinase inhibitors
JP4751398B2 (ja) * 2004-10-20 2011-08-17 エフ.ホフマン−ラ ロシュ アーゲー ハロゲン置換ベンゾジアゼピン誘導体
NZ554439A (en) * 2004-10-20 2009-09-25 Hoffmann La Roche Imidazo-benzodiazepine derivatives
AU2006301377B2 (en) * 2005-10-11 2012-03-08 F. Hoffmann-La Roche Ag Imidazo benzodiazepine derivatives
PE20080145A1 (es) * 2006-03-21 2008-02-11 Janssen Pharmaceutica Nv Tetrahidro-pirimidoazepinas como moduladores de trpv1
CL2007003244A1 (es) 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
JP5562865B2 (ja) 2007-12-17 2014-07-30 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Trpv1のイミダゾロ−、オキサゾロ−、及びチアゾロピリミジン・モジュレーター
CN101735211B (zh) * 2008-11-04 2012-11-14 复旦大学 2,3-二氢[1,5]苯并噻氮杂*类化合物或其盐在制备GSK-3β抑制剂中的用途
US7998952B2 (en) 2008-12-05 2011-08-16 Millennium Pharmaceuticals, Inc. Thiolactams and uses thereof
MX2011006725A (es) 2008-12-22 2011-09-15 Millennium Pharm Inc Combinacion de inhibidores de aurora cinasa y anticuerpos anti-cd20.
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
CN102770024A (zh) 2010-02-19 2012-11-07 米伦纽姆医药公司 4-{[9-氯-7-(2-氟-6-甲氧基苯基)-5h-嘧啶并[5,4-d][2]苯并氮杂卓-2基]氨基}-2-甲氧基苯甲酸钠的结晶形式
CN101891706B (zh) * 2010-04-09 2013-05-29 复旦大学 3,4-二氢苯并[f][1,4]噻氮杂*类化合物或其盐及其药物用途
CN102424670A (zh) * 2011-10-31 2012-04-25 江苏阿尔法药业有限公司 一种合成3-(3-氯丙基)-1,3,4,5-四氢-7,8-二甲氧基-2h-3-苯并氮杂卓-2-酮的方法
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
US20130303519A1 (en) 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
WO2014153509A1 (en) 2013-03-22 2014-09-25 Millennium Pharmaceuticals, Inc. Combination of catalytic mtorc 1/2 inhibitors and selective inhibitors of aurora a kinase
AU2014368961B2 (en) 2013-12-20 2019-10-17 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
EP3310785B1 (en) 2015-06-19 2024-11-20 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
JP2018524292A (ja) 2015-07-21 2018-08-30 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. オーロラキナーゼインヒビターと化学療法剤の投与
US20180170941A1 (en) 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US11505555B2 (en) 2016-12-19 2022-11-22 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
MX2020013927A (es) 2018-06-19 2021-03-02 Agenebio Inc Derivados de benzodiazepina, composiciones y metodos para tratar el deterioro cognitivo.
CN110452172B (zh) * 2019-08-21 2021-03-26 爱斯特(成都)生物制药股份有限公司 一种苯并己内酰胺的合成方法
CN112159411A (zh) * 2020-10-15 2021-01-01 南京工业大学 一种三氟甲基取代嘧啶并[1,3]二氮杂*化合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2607503B1 (fr) * 1986-12-02 1989-02-24 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
TW201311B (enExample) 1991-06-17 1993-03-01 Hoffmann La Roche
RU2119496C1 (ru) * 1992-04-14 1998-09-27 Научно-исследовательский институт фармакологии Российской академии медицинских наук Производные n-ацилпролилдипептидов
FR2728902B1 (fr) * 1994-12-29 1997-01-31 Synthelabo Derives d'acide 8-oxo-5,8-dihydro-6h-dibenzo(a,g)quinolizine-13-propanoique, leur preparation et leur application en therapeutique
WO1999043682A1 (en) * 1998-02-26 1999-09-02 Neurogen Corporation 2-(het-)aryl-4-(cyclic amino substituted) heteroaryl fused pyridine derivatives, their preparation and their use as (ant-)agonists for gaba (a) brain receptors
US6177569B1 (en) * 1998-08-25 2001-01-23 Neurogen Corporation Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands
FR2783828B1 (fr) 1998-09-29 2000-11-10 Synthelabo Derives d'acide 5,6-dihydro-4h-imidazo[1,2-a][1] benzazepine -1-acetique, leur preparation et leur application en therapeutique
ES2195943T3 (es) 1999-11-12 2003-12-16 Neurogen Corp Compuestos heteroaromaticos biciclicos y triciclicos.
TWI239333B (en) 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators

Similar Documents

Publication Publication Date Title
JP2004531563A5 (enExample)
RU2003136078A (ru) Имидазо[1,5-а] пиримидо[5,4-d][1] бензазепиновые производные в качестве модулято ров рецептора gaba a
JP2010523522A5 (enExample)
JP2004517070A5 (enExample)
JP3528968B2 (ja) 三環式複素環誘導体化合物およびその化合物を有効成分とする医薬
CN103096718B (zh) 可溶性鸟苷酸环化酶活化剂
JP2009542613A5 (enExample)
JP7038063B2 (ja) ピラゾロ[1,5-a]ピリミジニルカルボキサミド化合物および医学的障害の処置におけるその使用
CA2496194A1 (en) Phenyl-substituted pyrazolopyrimidines
WO2016203404A1 (en) Compounds and compositions for inhibiting the activity of shp2
JP2002535407A5 (enExample)
RU2003116895A (ru) Производные бензодиазепина в качестве модуляторов а рецептора гамк
JP2009084270A5 (enExample)
JP2010138190A5 (enExample)
JP2002535401A5 (enExample)
ES2892956T3 (es) Moduladores alostéricos positivos del receptor muscarínico de acetilcolina M4
JP2007538031A5 (enExample)
JP2005508969A5 (enExample)
RU2007112940A (ru) Производные имидазобензодиазепина
WO2006137527A1 (ja) チアゾール誘導体
RU2007112675A (ru) ПРОИЗВОДНЫЕ ИМИДАЗО[1,5-a]ТРИАЗОЛО[1,5-d]БЕНЗОДИАЗЕПИНА ДЛЯ ЛЕЧЕНИЯ КОГНИТИВНЫХ РАССТРОЙСТВ
JP2004528320A5 (enExample)
RU2007121767A (ru) Тетрациклические имидазо-бензодиазепины в качестве модуляторов гамк-рецепторов
CA2584757A1 (en) Halogen substituted benzodiazepine derivatives
JP2007512317A (ja) ピラゾロピリミジン類